1. Home
  2. DAO vs TRVI Comparison

DAO vs TRVI Comparison

Compare DAO & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youdao Inc. each representing one

DAO

Youdao Inc. each representing one

HOLD

Current Price

$12.08

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$13.60

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAO
TRVI
Founded
2006
2011
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
DAO
TRVI
Price
$12.08
$13.60
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$21.55
AVG Volume (30 Days)
89.3K
982.4K
Earning Date
05-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.91
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.24
N/A
Revenue Next Year
$14.60
N/A
P/E Ratio
$72.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.00
$5.41
52 Week High
$13.04
$16.12

Technical Indicators

Market Signals
Indicator
DAO
TRVI
Relative Strength Index (RSI) 53.71 45.75
Support Level $9.20 $13.12
Resistance Level $13.01 $14.57
Average True Range (ATR) 1.23 0.53
MACD -0.07 -0.11
Stochastic Oscillator 68.15 23.23

Price Performance

Historical Comparison
DAO
TRVI

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: